Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Dalton

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2023
β-Lactam Therapeutic Drug Monitoring in Critically Ill PatientsTeagan Zeggil, Bruce Dalton
European Journal of Hospital Pharmacy : Science and Practice|July 8, 2026
The antimicrobial 'three-body problem'Jackson J Stewart, Bruce Dalton
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2007
Trends in antimicrobial consumption may be affected by units of measureBruce Dalton, Deana Sabuda, John Conly
The Annals of Pharmacotherapy|January 31, 2008
Clinical pharmaceutics and calcium-ceftriaxoneAlfred S Gin, Hannah Wheaton, Bruce Dalton
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 11, 2021
Re: 'Cost-benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for Vancomycin' by Lee et alBruce Dalton, Elissa Rennert-May, Jackson Stewart
The Canadian Journal of Hospital Pharmacy|September 2, 2015
Histiocytoid Variant of Sweet Syndrome Associated with Azacitidine and Recurrence upon RechallengeSarah Bonazza, Bruce Dalton, Jori Hardin, et al.
The Canadian Journal of Hospital Pharmacy|April 26, 2013
Venous thromboembolism due to suspected interaction between rivaroxaban and nevirapineDuane Bates, Bruce Dalton, Janet Gilmour, et al.
International Journal of Antimicrobial Agents|September 4, 2020
Vancomycin AUC-guided therapeutic drug monitoring to reduce nephrotoxicity: are we overlooking a simpler solution? Comment on: Oda K, Jono H, Nosaka K, Saito H. Reduced nephrotoxicity in vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against trough 15-20 µg/mL concentrationSarah C J Jorgensen, Jackson J Stewart, Bruce Dalton
Clinical Genitourinary Cancer|January 22, 2014
Extensive necrotizing fasciitis associated with sunitinib therapyJolanta Piszczek, Bruce Dalton, Tess Peters, et al.
Transplantation|April 11, 2013
Predicting deficiency of vitamin D in renal transplant recipients in northern climatesLesley C Beique, Gregory A Kline, Bruce Dalton, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2023
β-Lactam Therapeutic Drug Monitoring in Critically Ill PatientsTeagan Zeggil, Bruce Dalton
European Journal of Hospital Pharmacy : Science and Practice|July 8, 2026
The antimicrobial 'three-body problem'Jackson J Stewart, Bruce Dalton
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2007
Trends in antimicrobial consumption may be affected by units of measureBruce Dalton, Deana Sabuda, John Conly
The Annals of Pharmacotherapy|January 31, 2008
Clinical pharmaceutics and calcium-ceftriaxoneAlfred S Gin, Hannah Wheaton, Bruce Dalton
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 11, 2021
Re: 'Cost-benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for Vancomycin' by Lee et alBruce Dalton, Elissa Rennert-May, Jackson Stewart
The Canadian Journal of Hospital Pharmacy|September 2, 2015
Histiocytoid Variant of Sweet Syndrome Associated with Azacitidine and Recurrence upon RechallengeSarah Bonazza, Bruce Dalton, Jori Hardin, et al.
The Canadian Journal of Hospital Pharmacy|April 26, 2013
Venous thromboembolism due to suspected interaction between rivaroxaban and nevirapineDuane Bates, Bruce Dalton, Janet Gilmour, et al.
International Journal of Antimicrobial Agents|September 4, 2020
Vancomycin AUC-guided therapeutic drug monitoring to reduce nephrotoxicity: are we overlooking a simpler solution? Comment on: Oda K, Jono H, Nosaka K, Saito H. Reduced nephrotoxicity in vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against trough 15-20 µg/mL concentrationSarah C J Jorgensen, Jackson J Stewart, Bruce Dalton
Clinical Genitourinary Cancer|January 22, 2014
Extensive necrotizing fasciitis associated with sunitinib therapyJolanta Piszczek, Bruce Dalton, Tess Peters, et al.
Transplantation|April 11, 2013
Predicting deficiency of vitamin D in renal transplant recipients in northern climatesLesley C Beique, Gregory A Kline, Bruce Dalton, et al.
Pageof 3